Frankel Stanley purchased $6K of DTIL
Frankel Stanley purchased 1,000 shares of PRECISION BIOSCIENCES INC (DTIL) at $6.00 on 2026-09-28.
How this was made
The 30-second read
Why it matters
The $6,000 purchase is a routine insider transaction with negligible impact on price or sentiment.
Market read
Minor insider purchase; unlikely to affect trading decisions.
What to watch
The director's cumulative holdings may indicate longer‑term commitment despite the modest purchase size.
Background
Form 4 filings disclose insider transactions; they are primary sources for corporate insider activity.
Ticker impact
Director Frankel Stanley bought 1,000 shares of Precision Biosciences for $6,000, increasing his stake to 41,478 shares.
little upward pressure as the market may view the purchase as a modest vote of confidence
The transaction size ($6K) is trivial for a public company and unlikely to move the stock price.
Market effects
None; the purchase does not affect the broader biotech sector.
None; limited to U.S. investors.
None; the filing is a routine insider transaction.
Counterpoint
Even small insider buys can signal confidence; watch for future purchases.
Key entities
- companyPrecision Biosciences Inc.
Biotech firm developing gene‑editing therapies.
- personFrankel Stanley
Director of Precision Biosciences who made the purchase.